Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
144.6 SEK | +1.83% | +3.06% | -20.77% |
May. 15 | Surgical Science Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB | CI |
Sales 2024 * | 939M 89.19M | Sales 2025 * | 1.16B 110M | Capitalization | 7.38B 701M |
---|---|---|---|---|---|
Net income 2024 * | 186M 17.67M | Net income 2025 * | 287M 27.27M | EV / Sales 2024 * | 6.99 x |
Net cash position 2024 * | 818M 77.69M | Net cash position 2025 * | 1.1B 105M | EV / Sales 2025 * | 5.42 x |
P/E ratio 2024 * |
39.5
x | P/E ratio 2025 * |
25.7
x | Employees | 265 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 73.33% |
Latest transcript on Surgical Science Sweden AB
1 day | +1.83% | ||
1 week | +3.06% | ||
1 month | -7.96% | ||
3 months | -3.15% | ||
6 months | -15.04% | ||
Current year | -20.77% |
Managers | Title | Age | Since |
---|---|---|---|
Anders Larsson
FOU | Founder | 51 | 97-07-23 |
Gisli Hennermark
CEO | Chief Executive Officer | 52 | 14-12-31 |
Director of Finance/CFO | 54 | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roland Bengtsson
CHM | Chairman | 69 | 04-12-31 |
Director/Board Member | 57 | 16-12-31 | |
Director/Board Member | 49 | 21-05-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 5 M€ | +15.85% | ||
0.00% | 10 M€ | -3.35% | - | |
0.00% | 146 M€ | -2.63% | - | |
0.00% | 25 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 144.6 | +1.83% | 151,235 |
24-05-30 | 142 | +1.50% | 61,181 |
24-05-29 | 139.9 | -2.58% | 78,126 |
24-05-28 | 143.6 | +1.70% | 67,546 |
24-05-27 | 141.2 | +0.64% | 29,242 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.77% | 700M | |
-9.49% | 28.16B | |
+25.35% | 8.33B | |
+33.25% | 4.39B | |
-35.85% | 2.43B | |
-9.44% | 1.6B | |
-13.39% | 1.5B | |
-32.84% | 1.15B | |
+7.80% | 964M | |
-37.56% | 872M |
- Stock Market
- Equities
- SUS Stock